Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells. [electronic resource]
Producer: 20190429Description: 135 p. digitalISSN:- 1530-9932
- Administration, Oral
- Animals
- Antineoplastic Agents -- chemistry
- Biological Availability
- Calcium Compounds -- chemistry
- Carcinoma, Non-Small-Cell Lung -- metabolism
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm
- Erlotinib Hydrochloride -- chemistry
- Humans
- Lung Neoplasms -- metabolism
- Polyethylene Glycols -- chemistry
- Rats
- Rats, Sprague-Dawley
- Silicates -- chemistry
- Solubility
- Valproic Acid -- chemistry
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.